Expression	NN	B-NP	O	Other	Other	Other	Other	B-Gene_expression	###	1	Expression	Expression	NN	NN	_	4	nsubj	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	2	of	of	IN	IN	_	3	case	_	_
c-fos	NN	B-NP	B-DNA	B-Protein	Other	Other	B-Protein	Other	###	3	c-fos	c-fos	NN	NN	_	1	nmod	_	_
correlates	VBZ	B-VP	O	Other	Other	Other	Other	Other	###	4	correlates	correlates	VBZ	VBZ	_	0	root	_	_
with	IN	B-PP	O	Other	Other	Other	Other	Other	###	5	with	with	IN	IN	_	7	case	_	_
IFN-alpha	NN	B-NP	B-protein	Other	Other	Other	Other	Other	###	6	IFN-alpha	IFN-alpha	NN	NN	_	7	compound	_	_
responsiveness	NN	I-NP	O	Other	Other	Other	Other	Other	###	7	responsiveness	responsiveness	NN	NN	_	4	nmod	_	_
in	IN	B-PP	O	Other	Other	Other	Other	Other	###	8	in	in	IN	IN	_	14	case	_	_
Philadelphia	NNP	B-NP	O	Other	Other	Other	Other	Other	###	9	Philadelphia	Philadelphia	NNP	NNP	_	14	compound	_	_
chromosome	NN	I-NP	O	Other	Other	Other	Other	Other	###	10	chromosome	chromosome	NN	NN	_	14	compound	_	_
positive	JJ	I-NP	O	Other	Other	Other	Other	Other	###	11	positive	positive	JJ	JJ	_	14	amod	_	_
chronic	JJ	I-NP	O	Other	Other	Other	Other	Other	###	12	chronic	chronic	JJ	JJ	_	14	amod	_	_
myelogenous	JJ	I-NP	O	Other	Other	Other	Other	Other	###	13	myelogenous	myelogenous	JJ	JJ	_	14	amod	_	_
leukemia	NN	I-NP	O	Other	Other	Other	Other	Other	###	14	leukemia	leukemia	NN	NN	_	7	nmod	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	15	.	.	.	.	_	4	punct	_	_

This	DT	B-NP	O	Other	Other	Other	Other	Other	###	1	This	This	DT	DT	_	2	det	_	_
study	NN	I-NP	O	Other	Other	Other	Other	Other	###	2	study	study	NN	NN	_	3	nsubj	_	_
evaluates	VBZ	B-VP	O	Other	Other	Other	Other	Other	###	3	evaluates	evaluates	VBZ	VBZ	_	0	root	_	_
(	(	B-LST	O	Other	Other	Other	Other	Other	###	4	(	(	(	(	_	5	punct	_	_
i	LS	I-LST	O	Other	Other	Other	Other	Other	###	5	i	i	LS	LS	_	8	dep	_	_
)	)	O	O	Other	Other	Other	Other	Other	###	6	)	)	)	)	_	5	punct	_	_
constitutive	JJ	B-NP	O	Other	Other	Other	Other	Other	###	7	constitutive	constitutive	JJ	JJ	_	8	amod	_	_
levels	NNS	I-NP	O	Other	Other	Other	Other	B-Transcription	###	8	levels	levels	NNS	NNS	_	3	dobj	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	9	of	of	IN	IN	_	13	case	_	_
oncogene	NN	B-NP	B-DNA	Other	Other	Other	Other	Other	###	10	oncogene	oncogene	NN	NN	_	8	nmod	_	_
and	CC	I-NP	O	Other	Other	Other	Other	Other	###	11	and	and	CC	CC	_	10	cc	_	_
p53	NN	I-NP	B-RNA	B-Protein	Other	Other	B-Protein	Other	###	12	p53	p53	NN	NN	_	10	conj	_	_
transcripts	NNS	I-NP	I-RNA	Other	Other	Other	Other	Other	###	13	transcripts	transcripts	NNS	NNS	_	10	dep	_	_
in	IN	B-PP	O	Other	Other	Other	Other	Other	###	14	in	in	IN	IN	_	18	case	_	_
chronic	JJ	B-NP	O	Other	Other	Other	Other	Other	###	15	chronic	chronic	JJ	JJ	_	18	amod	_	_
phase	NN	I-NP	O	Other	Other	Other	Other	Other	###	16	phase	phase	NN	NN	_	18	compound	_	_
CML	NN	I-NP	O	Other	Other	Other	Other	Other	###	17	CML	CML	NN	NN	_	18	compound	_	_
patients	NNS	I-NP	O	Other	Other	Other	Other	Other	###	18	patients	patients	NNS	NNS	_	8	nmod	_	_
and	CC	O	O	Other	Other	Other	Other	Other	###	19	and	and	CC	CC	_	8	cc	_	_
(	(	B-LST	O	Other	Other	Other	Other	Other	###	20	(	(	(	(	_	21	punct	_	_
ii	LS	I-LST	O	Other	Other	Other	Other	Other	###	21	ii	ii	LS	LS	_	24	dep	_	_
)	)	O	O	Other	Other	Other	Other	Other	###	22	)	)	)	)	_	21	punct	_	_
their	PRP$	B-NP	O	Other	Other	Other	Other	Other	###	23	their	their	PRP$	PRP$	_	24	nmod:poss	_	_
modulations	NNS	I-NP	O	Other	Other	Other	Other	Other	###	24	modulations	modulations	NNS	NNS	_	8	conj	_	_
subsequent	JJ	B-ADJP	O	Other	Other	Other	Other	Other	###	25	subsequent	subsequent	JJ	JJ	_	24	amod	_	_
to	TO	B-PP	O	Other	Other	Other	Other	Other	###	26	to	to	TO	TO	_	29	case	_	_
in	FW	B-NP	O	Other	Other	Other	Other	Other	###	27	in	in	FW	FW	_	29	amod	_	_
vivo	FW	I-NP	O	Other	Other	Other	Other	Other	###	28	vivo	vivo	FW	FW	_	27	dep	_	_
therapy	NN	I-NP	O	Other	Other	Other	Other	Other	###	29	therapy	therapy	NN	NN	_	25	nmod	_	_
with	IN	B-PP	O	Other	Other	Other	Other	Other	###	30	with	with	IN	IN	_	32	case	_	_
rIFN-alpha	NN	B-NP	B-protein	Other	Other	Other	Other	Other	###	31	rIFN-alpha	rIFN-alpha	NN	NN	_	32	compound	_	_
2c	NN	I-NP	I-protein	Other	Other	Other	Other	Other	###	32	2c	2c	NN	NN	_	29	nmod	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	33	.	.	.	.	_	3	punct	_	_

Peripheral	JJ	B-NP	B-cell_type	Other	Other	Other	Other	Other	###	1	Peripheral	Peripheral	JJ	JJ	_	4	amod	_	_
blood	NN	I-NP	I-cell_type	Other	Other	Other	Other	Other	###	2	blood	blood	NN	NN	_	4	compound	_	_
mononuclear	JJ	I-NP	I-cell_type	Other	Other	Other	Other	Other	###	3	mononuclear	mononuclear	JJ	JJ	_	4	amod	_	_
cells	NNS	I-NP	I-cell_type	Other	Other	Other	Other	Other	###	4	cells	cells	NNS	NNS	_	16	nsubjpass	_	_
(	(	O	O	Other	Other	Other	Other	Other	###	5	(	(	(	(	_	6	punct	_	_
pbmc	NN	B-NP	B-cell_type	Other	Other	Other	Other	Other	###	6	pbmc	pbmc	NN	NN	_	4	appos	_	_
)	)	O	O	Other	Other	Other	Other	Other	###	7	)	)	)	)	_	6	punct	_	_
and	CC	O	O	Other	Other	Other	Other	Other	###	8	and	and	CC	CC	_	4	cc	_	_
bone	NN	B-NP	B-cell_type	Other	Other	Other	Other	Other	###	9	bone	bone	NN	NN	_	11	compound	_	_
marrow	NN	I-NP	I-cell_type	Other	Other	Other	Other	Other	###	10	marrow	marrow	NN	NN	_	11	compound	_	_
cells	NNS	I-NP	I-cell_type	Other	Other	Other	Other	Other	###	11	cells	cells	NNS	NNS	_	4	conj	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	12	of	of	IN	IN	_	14	case	_	_
26	CD	B-NP	O	Other	Other	Other	Other	Other	###	13	26	26	CD	CD	_	14	nummod	_	_
patients	NNS	I-NP	O	Other	Other	Other	Other	Other	###	14	patients	patients	NNS	NNS	_	11	nmod	_	_
were	VBD	B-VP	O	Other	Other	Other	Other	Other	###	15	were	were	VBD	VBD	_	16	auxpass	_	_
examined	VBN	I-VP	O	Other	Other	Other	Other	Other	###	16	examined	examined	VBN	VBN	_	0	root	_	_
for	IN	B-PP	O	Other	Other	Other	Other	Other	###	17	for	for	IN	IN	_	18	case	_	_
c-fos	NN	B-NP	B-DNA	B-Protein	B-Protein	Other	B-Protein	Other	###	18	c-fos	c-fos	NN	NN	_	16	nmod	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	19	,	,	,	,	_	18	punct	_	_
c-myc	NN	B-NP	B-DNA	B-Protein	Other	Other	B-Protein	Other	###	20	c-myc	c-myc	NN	NN	_	18	conj	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	21	,	,	,	,	_	18	punct	_	_
p53	NN	B-NP	B-protein	B-Protein	B-Protein	Other	B-Protein	Other	###	22	p53	p53	NN	NN	_	18	conj	_	_
and	CC	O	O	Other	Other	Other	Other	Other	###	23	and	and	CC	CC	_	18	cc	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	24	the	the	DT	DT	_	30	det	_	_
hybrid	NN	I-NP	O	Other	Other	Other	Other	Other	###	25	hybrid	hybrid	NN	NN	_	29	compound	_	_
bcr	NN	I-NP	O	Other	Other	Other	Other	Other	###	26	bcr	bcr	NN	NN	_	29	compound	_	_
/	/	O	O	Other	Other	Other	Other	Other	###	27	/	/	/	/	_	29	punct	_	_
abl	NN	I-NP	O	Other	Other	Other	Other	Other	###	28	abl	abl	NN	NN	_	29	compound	_	_
mRNA	NN	I-NP	O	Other	Other	Other	Other	Other	###	29	mRNA	mRNA	NN	NN	_	30	compound	_	_
levels	NNS	I-NP	O	Other	Other	B-Transcription	Other	B-Transcription	###	30	levels	levels	NNS	NNS	_	18	conj	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	31	.	.	.	.	_	16	punct	_	_

Results	NNS	B-NP	O	Other	Other	Other	Other	Other	###	1	Results	Results	NNS	NNS	_	2	nsubj	_	_
indicated	VBD	B-VP	O	Other	Other	Other	Other	Other	###	2	indicated	indicated	VBD	VBD	_	0	root	_	_
that	IN	B-SBAR	O	Other	Other	Other	Other	Other	###	3	that	that	IN	IN	_	13	mark	_	_
(	(	B-LST	O	Other	Other	Other	Other	Other	###	4	(	(	(	(	_	5	punct	_	_
i	LS	I-LST	O	Other	Other	Other	Other	Other	###	5	i	i	LS	LS	_	13	dep	_	_
)	)	O	O	Other	Other	Other	Other	Other	###	6	)	)	)	)	_	5	punct	_	_
constitutive	JJ	B-NP	O	Other	Other	Other	Other	Other	###	7	constitutive	constitutive	JJ	JJ	_	10	amod	_	_
c-fos	NN	I-NP	B-RNA	Other	Other	Other	Other	Other	###	8	c-fos	c-fos	NN	NN	_	10	compound	_	_
transcript	NN	I-NP	I-RNA	Other	Other	Other	Other	Other	###	9	transcript	transcript	NN	NN	_	10	compound	_	_
levels	NNS	I-NP	O	Other	Other	Other	Other	Other	###	10	levels	levels	NNS	NNS	_	13	nsubj	_	_
are	VBP	B-VP	O	Other	Other	Other	Other	Other	###	11	are	are	VBP	VBP	_	13	cop	_	_
significantly	RB	B-ADJP	O	Other	Other	Other	Other	Other	###	12	significantly	significantly	RB	RB	_	13	advmod	_	_
higher	JJR	I-ADJP	O	Other	Other	Other	Other	Other	###	13	higher	higher	JJR	JJR	_	2	ccomp	_	_
in	IN	B-PP	O	Other	Other	Other	Other	Other	###	14	in	in	IN	IN	_	15	case	_	_
patients	NNS	B-NP	O	Other	Other	Other	Other	Other	###	15	patients	patients	NNS	NNS	_	13	nmod	_	_
subsequently	RB	B-VP	O	Other	Other	Other	Other	Other	###	16	subsequently	subsequently	RB	RB	_	17	advmod	_	_
responding	VBG	I-VP	O	Other	Other	Other	Other	Other	###	17	responding	responding	VBG	VBG	_	15	acl	_	_
to	TO	B-PP	O	Other	Other	Other	Other	Other	###	18	to	to	TO	TO	_	20	case	_	_
IFN-alpha	NN	B-NP	B-protein	Other	Other	Other	Other	Other	###	19	IFN-alpha	IFN-alpha	NN	NN	_	20	compound	_	_
therapy	NN	I-NP	O	Other	Other	Other	Other	Other	###	20	therapy	therapy	NN	NN	_	17	nmod	_	_
(	(	O	O	Other	Other	Other	Other	Other	###	21	(	(	(	(	_	24	punct	_	_
p	NN	B-NP	O	Other	Other	Other	Other	Other	###	22	p	p	NN	NN	_	24	nsubj	_	_
<	SYM	O	O	Other	Other	Other	Other	Other	###	23	<	<	SYM	SYM	_	24	dep	_	_
0.01	CD	B-NP	O	Other	Other	Other	Other	Other	###	24	0.01	0.01	CD	CD	_	13	parataxis	_	_
)	)	O	O	Other	Other	Other	Other	Other	###	25	)	)	)	)	_	24	punct	_	_
and	CC	O	O	Other	Other	Other	Other	Other	###	26	and	and	CC	CC	_	13	cc	_	_
positively	RB	B-VP	O	Other	Other	Other	Other	Other	###	27	positively	positively	RB	RB	_	28	advmod	_	_
correlated	VBD	I-VP	O	Other	Other	Other	Other	Other	###	28	correlated	correlated	VBD	VBD	_	13	conj	_	_
with	IN	B-PP	O	Other	Other	Other	Other	Other	###	29	with	with	IN	IN	_	31	case	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	30	the	the	DT	DT	_	31	det	_	_
proportion	NN	I-NP	O	Other	Other	Other	Other	Other	###	31	proportion	proportion	NN	NN	_	28	nmod	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	32	of	of	IN	IN	_	33	case	_	_
lymphocytes	NNS	B-NP	B-cell_type	Other	Other	Other	Other	Other	###	33	lymphocytes	lymphocytes	NNS	NNS	_	31	nmod	_	_
(	(	O	O	Other	Other	Other	Other	Other	###	34	(	(	(	(	_	36	punct	_	_
r	NN	B-NP	O	Other	Other	Other	Other	Other	###	35	r	r	NN	NN	_	36	nsubj	_	_
=	SYM	B-VP	O	Other	Other	Other	Other	Other	###	36	=	=	SYM	SYM	_	31	dep	_	_
0.6895	CD	B-NP	O	Other	Other	Other	Other	Other	###	37	0.6895	0.6895	CD	CD	_	36	dobj	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	38	,	,	,	,	_	36	punct	_	_
p	NN	B-NP	O	Other	Other	Other	Other	Other	###	39	p	p	NN	NN	_	41	dep	_	_
<	SYM	B-NP	O	Other	Other	Other	Other	Other	###	40	<	<	SYM	SYM	_	41	dep	_	_
0.01	CD	I-NP	O	Other	Other	Other	Other	Other	###	41	0.01	0.01	CD	CD	_	36	parataxis	_	_
)	)	O	O	Other	Other	Other	Other	Other	###	42	)	)	)	)	_	36	punct	_	_
and	CC	O	O	Other	Other	Other	Other	Other	###	43	and	and	CC	CC	_	31	cc	_	_
negatively	RB	B-ADVP	O	Other	Other	Other	Other	Other	###	44	negatively	negatively	RB	RB	_	47	advmod	_	_
with	IN	B-PP	O	Other	Other	Other	Other	Other	###	45	with	with	IN	IN	_	47	case	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	46	the	the	DT	DT	_	47	det	_	_
proportion	NN	I-NP	O	Other	Other	Other	Other	Other	###	47	proportion	proportion	NN	NN	_	31	conj	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	48	of	of	IN	IN	_	50	case	_	_
immature	JJ	B-NP	B-cell_type	Other	Other	Other	Other	Other	###	49	immature	immature	JJ	JJ	_	50	amod	_	_
cells	NNS	I-NP	I-cell_type	Other	Other	Other	Other	Other	###	50	cells	cells	NNS	NNS	_	47	nmod	_	_
(	(	O	O	Other	Other	Other	Other	Other	###	51	(	(	(	(	_	53	punct	_	_
r	NN	B-NP	O	Other	Other	Other	Other	Other	###	52	r	r	NN	NN	_	53	nsubj	_	_
=	SYM	B-VP	O	Other	Other	Other	Other	Other	###	53	=	=	SYM	SYM	_	47	dep	_	_
-0.568	CD	B-NP	O	Other	Other	Other	Other	Other	###	54	-0.568	-0.568	CD	CD	_	53	dobj	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	55	,	,	,	,	_	53	punct	_	_
p	NN	B-NP	O	Other	Other	Other	Other	Other	###	56	p	p	NN	NN	_	58	dep	_	_
<	SYM	B-NP	O	Other	Other	Other	Other	Other	###	57	<	<	SYM	SYM	_	58	dep	_	_
0.01	CD	I-NP	O	Other	Other	Other	Other	Other	###	58	0.01	0.01	CD	CD	_	53	parataxis	_	_
)	)	O	O	Other	Other	Other	Other	Other	###	59	)	)	)	)	_	53	punct	_	_
contained	VBN	B-VP	O	Other	Other	Other	Other	Other	###	60	contained	contained	VBN	VBN	_	50	acl	_	_
in	IN	B-PP	O	Other	Other	Other	Other	Other	###	61	in	in	IN	IN	_	64	case	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	62	the	the	DT	DT	_	64	det	_	_
pbmc	NN	I-NP	B-cell_type	Other	Other	Other	Other	Other	###	63	pbmc	pbmc	NN	NN	_	64	compound	_	_
preparations	NNS	I-NP	O	Other	Other	Other	Other	Other	###	64	preparations	preparations	NNS	NNS	_	60	nmod	_	_
tested	VBN	B-VP	O	Other	Other	Other	Other	Other	###	65	tested	tested	VBN	VBN	_	64	acl	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	66	,	,	,	,	_	85	punct	_	_
(	(	B-LST	O	Other	Other	Other	Other	Other	###	67	(	(	(	(	_	68	punct	_	_
ii	LS	I-LST	O	Other	Other	Other	Other	Other	###	68	ii	ii	LS	LS	_	85	dep	_	_
)	)	O	O	Other	Other	Other	Other	Other	###	69	)	)	)	)	_	68	punct	_	_
constitutive	JJ	B-NP	B-RNA	Other	Other	Other	Other	Other	###	70	constitutive	constitutive	JJ	JJ	_	72	amod	_	_
mRNA	NN	I-NP	I-RNA	Other	Other	Other	Other	Other	###	71	mRNA	mRNA	NN	NN	_	72	compound	_	_
levels	NNS	I-NP	O	Other	Other	Other	Other	Other	###	72	levels	levels	NNS	NNS	_	85	nsubjpass	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	73	of	of	IN	IN	_	76	case	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	74	the	the	DT	DT	_	76	det	_	_
hybrid	NN	I-NP	B-DNA	Other	Other	Other	Other	Other	###	75	hybrid	hybrid	NN	NN	_	76	compound	_	_
bcr	NN	I-NP	I-DNA	Other	Other	Other	Other	Other	###	76	bcr	bcr	NN	NN	_	72	nmod	_	_
/	/	O	O	Other	Other	Other	Other	Other	###	77	/	/	/	/	_	76	punct	_	_
abl	NN	I-NP	I-DNA	Other	Other	Other	Other	Other	###	78	abl	abl	NN	NN	_	76	dep	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	79	,	,	,	,	_	78	punct	_	_
c-myc	NN	B-NP	B-DNA	B-Protein	B-Protein	Other	Other	Other	###	80	c-myc	c-myc	NN	NN	_	78	conj	_	_
and	CC	I-NP	O	Other	Other	Other	Other	Other	###	81	and	and	CC	CC	_	78	cc	_	_
p53	NN	I-NP	B-protein	B-Protein	B-Protein	Other	Other	Other	###	82	p53	p53	NN	NN	_	78	conj	_	_
are	VBP	B-VP	O	Other	Other	Other	Other	Other	###	83	are	are	VBP	VBP	_	85	auxpass	_	_
positively	RB	I-VP	O	Other	Other	Other	Other	Other	###	84	positively	positively	RB	RB	_	85	advmod	_	_
correlated	VBN	I-VP	O	Other	Other	Other	Other	Other	###	85	correlated	correlated	VBN	VBN	_	13	conj	_	_
with	IN	B-PP	O	Other	Other	Other	Other	Other	###	86	with	with	IN	IN	_	88	case	_	_
each	DT	B-NP	O	Other	Other	Other	Other	Other	###	87	each	each	DT	DT	_	88	det	_	_
other	JJ	I-NP	O	Other	Other	Other	Other	Other	###	88	other	other	JJ	JJ	_	85	nmod	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	89	,	,	,	,	_	85	punct	_	_
but	CC	O	O	Other	Other	Other	Other	Other	###	90	but	but	CC	CC	_	85	cc	_	_
failed	VBD	B-VP	O	Other	Other	Other	Other	Other	###	91	failed	failed	VBD	VBD	_	85	conj	_	_
to	TO	I-VP	O	Other	Other	Other	Other	Other	###	92	to	to	TO	TO	_	93	mark	_	_
relate	VB	I-VP	O	Other	Other	Other	Other	Other	###	93	relate	relate	VB	VB	_	91	xcomp	_	_
to	TO	B-PP	O	Other	Other	Other	Other	Other	###	94	to	to	TO	TO	_	96	case	_	_
disease	NN	B-NP	O	Other	Other	Other	Other	Other	###	95	disease	disease	NN	NN	_	96	compound	_	_
parameters	NNS	I-NP	O	Other	Other	Other	Other	Other	###	96	parameters	parameters	NNS	NNS	_	93	nmod	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	97	,	,	,	,	_	13	punct	_	_
and	CC	O	O	Other	Other	Other	Other	Other	###	98	and	and	CC	CC	_	13	cc	_	_
(	(	B-LST	O	Other	Other	Other	Other	Other	###	99	(	(	(	(	_	100	punct	_	_
iii	LS	I-LST	O	Other	Other	Other	Other	Other	###	100	iii	iii	LS	LS	_	111	dep	_	_
)	)	O	O	Other	Other	Other	Other	Other	###	101	)	)	)	)	_	100	punct	_	_
acute	JJ	B-NP	O	Other	Other	Other	Other	Other	###	102	acute	acute	JJ	JJ	_	111	nsubjpass	_	_
and	CC	I-NP	O	Other	Other	Other	Other	Other	###	103	and	and	CC	CC	_	102	cc	_	_
chronic	JJ	I-NP	O	Other	Other	Other	Other	Other	###	104	chronic	chronic	JJ	JJ	_	102	conj	_	_
in	FW	I-NP	O	Other	Other	Other	Other	Other	###	105	in	in	FW	FW	_	107	amod	_	_
vivo	FW	I-NP	O	Other	Other	Other	Other	Other	###	106	vivo	vivo	FW	FW	_	105	dep	_	_
exposure	NN	I-NP	O	Other	Other	Other	Other	Other	###	107	exposure	exposure	NN	NN	_	102	dep	_	_
to	TO	B-PP	O	Other	Other	Other	Other	Other	###	108	to	to	TO	TO	_	109	case	_	_
IFN-alpha	NN	B-NP	B-protein	Other	Other	Other	Other	Other	###	109	IFN-alpha	IFN-alpha	NN	NN	_	107	nmod	_	_
is	VBZ	B-VP	O	Other	Other	Other	Other	Other	###	110	is	is	VBZ	VBZ	_	111	auxpass	_	_
accompanied	VBN	I-VP	O	Other	Other	Other	Other	B-Positive_regulation	###	111	accompanied	accompanied	VBN	VBN	_	13	conj	_	_
by	IN	B-PP	O	Other	Other	Other	Other	I-Positive_regulation	###	112	by	by	IN	IN	_	113	case	_	_
upregulation	NN	B-NP	O	Other	Other	Other	Other	I-Positive_regulation	###	113	upregulation	upregulation	NN	NN	_	111	nmod	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	114	of	of	IN	IN	_	115	case	_	_
c-fos	NN	B-NP	B-DNA	B-Protein	B-Protein	Other	B-Protein	Other	###	115	c-fos	c-fos	NN	NN	_	113	nmod	_	_
and	CC	O	O	Other	Other	Other	Other	Other	###	116	and	and	CC	CC	_	113	cc	_	_
downregulation	NN	B-NP	O	Other	Other	Other	Other	B-Negative_regulation	###	117	downregulation	downregulation	NN	NN	_	113	conj	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	118	of	of	IN	IN	_	121	case	_	_
c-myc	NN	B-NP	B-RNA	B-Protein	B-Protein	Other	B-Protein	Other	###	119	c-myc	c-myc	NN	NN	_	121	compound	_	_
mRNA	NN	I-NP	I-RNA	Other	Other	Other	Other	Other	###	120	mRNA	mRNA	NN	NN	_	121	compound	_	_
levels	NNS	I-NP	O	Other	Other	Other	Other	Other	###	121	levels	levels	NNS	NNS	_	117	nmod	_	_
in	IN	B-PP	O	Other	Other	Other	Other	Other	###	122	in	in	IN	IN	_	124	case	_	_
responder	NN	B-NP	O	Other	Other	Other	Other	Other	###	123	responder	responder	NN	NN	_	124	compound	_	_
patients	NNS	I-NP	O	Other	Other	Other	Other	Other	###	124	patients	patients	NNS	NNS	_	117	nmod	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	125	.	.	.	.	_	2	punct	_	_

